Stock A068270CELLTRION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 21/04/2025 		5-day change 1st Jan Change
157,400.00 KRW 0.00% Intraday chart for Celltrion, Inc. -2.30% -16.05%
04-18 South Korean Shares Little Changed as Trump Says US 'in No Rush' to Make Deals with Trade Partners MT
04-17 Shilpa Medicare Enters Into Settlement With Celltrion RE

Chart calendar Celltrion, Inc.

cc0bc443a7f0128a15f033b09.mBERUrdk3F8IpZAnYFe1iVugxs4gniTSn-hJF8vqofI.8UBmCPYKsWhb1cRzUQTT7SGX8v1apmC53KccJqOFyLqgYlU-wh2DEXiV5w~b890b91eb26e37522375f9501be2011e

Upcoming events on Celltrion, Inc.

07/05/2025 Q1 2025 Earnings Release (Projected)
07/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)
06/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Celltrion, Inc.

24/02/2025 Q4 2024 Earnings Release
27/11/2024 07:00 Investor Meeting
07/11/2024 Q3 2024 Earnings Release
13/08/2024 Q2 2024 Earnings Release
08/05/2024 Q1 2024 Earnings Release
28/02/2024 Q4 2023 Earnings Release
09/01/2024 JPMorgan Healthcare Conference
06/11/2023 Q3 2023 Earnings Release
12/09/2023 Roadshow - Day - 2
11/09/2023 Roadshow - Day - 1
11/09/2023 20:35 Morgan Stanley Global Healthcare Conference - Fireside Chat
24/08/2023 08:00 Investor Meeting
17/08/2023 08:30 Investor Meeting
07/05/2023 Q1 2023 Earnings Release
19/03/2023 Q4 2022 Earnings Release
13/11/2022 Q3 2022 Earnings Release
15/08/2022 Interim 2022 Earnings Release
15/05/2022 Q1 2022 Earnings Release
15/02/2022 FY 2021 Earnings Release
09/11/2021 Q3 2021 Earnings Release

Past dividends on Celltrion, Inc.

26/12/2024 Annual 750 KRW
26/12/2023 Annual 500 KRW
27/12/2022 Annual 375 KRW
28/12/2021 Annual 750 KRW
26/12/2012 Annual 15 KRW
27/12/2011 Annual 100 KRW
28/12/2010 Annual 75 KRW
26/12/2007 Annual 50 KRW

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Billions KRW		Released
Forecast
Spread 		2 284
2 367
-3.53%		2 176
2 369
-8.11%		3 557
3 498
1.68%
4 464


5 380


6 230

EBITDA
Billions KRW		Released
Forecast
Spread 		874
981
-10.95%		897
1 024
-12.4%		910
957
-4.88%
1 688


2 254


2 711

EBIT
Billions KRW		Released
Forecast
Spread 		647
751
-13.82%		651
836
-22.03%		492
569
-13.59%
1 347


1 900


2 419

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		626
799
-21.59%		671
834
-19.5%		576
569
1.22%
1 353


1 852


2 106

Net income
Billions KRW		Released
Forecast
Spread 		533
622
-14.21%		536
703
-23.81%		423
441
-4.08%
1 058


1 451


1 649

EPS
KRW		Released
Forecast
Spread 		3 671
4 103
-10.52%		3 574
4 619
-22.62%		2 045
1 937
5.59%
4 836


6 785


8 055

Announcement Date03/03/2329/02/2425/02/25-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		524
606
-13.58%		672
646
4.09%		383
581
-34.19%		737
722
2.1%		875
804
8.84%		882
936
-5.75%		1 064
1 018
4.48%
929


1 065


1 161


1 307


1 192


1 353


1 467


1 521

EBITDA
Billions KRW		Released
Forecast
Spread








147
103
42.76%		205
198
3.28%		283
290
-2.24%		275
282
-2.47%
266


348


464


540













EBIT
Billions KRW		Released
Forecast
Spread 		183
193
-5.26%		268
224
19.62%		18,4
186
-90.07%		15,4
7,44
107.41%		72,5
77,0
-5.9%		208
213
-2.41%		196
270
-27.2%
208


287


356


430


396


493


538


611

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		190
180
5.68%		283
224
26.02%





104
82,6
26.15%		178
208
-14.47%		274
280
-2.13%
166


248


318


446













Net income
Billions KRW		Released
Forecast
Spread 		148
156
-5.57%		222
174
27.63%		1,05
167
-99.37%		22,4
7,67
192.67%		78,0
63,8
22.24%		85,6
171
-49.99%		237
219
8.29%
154


215


279


318













EPS
KRW		Released
Forecast
Spread 		985
964
2.12%		1 487
1 045
42.29%





359
248
44.62%		394
823
-52.1%		1 146
928
23.47%
698


1 159


1 165


1 539













Announcement Date14/08/2307/11/2329/02/2409/05/2407/08/2408/11/2425/02/25--------

Upcoming sector events for Celltrion, Inc.

24/04/2025 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2025 Earnings Release (Projected)
24/04/2025 SHANGHAI MEDICILON INC.: Q1 2025 Earnings Release (Projected)
24/04/2025 PHARMARON BEIJING CO., LTD.: Q1 2025 Earnings Release
24/04/2025 GEMPHARMATECH CO., LTD.: Q1 2025 Earnings Release (Projected)
24/04/2025 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q4 2024 Earnings Release
25/04/2025 06:00 BB BIOTECH AG: Q1 2025 Earnings Release
25/04/2025 GEMPHARMATECH CO., LTD.: Q4 2024 Earnings Release
27/04/2025 HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2025 Earnings Release
27/04/2025 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2024 Earnings Release
28/04/2025 R&G PHARMASTUDIES CO., LTD.: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Celltrion, Inc.

Today SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2025 Earnings Release (Projected)
Today JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2025 Earnings Release (Projected)
Today BIDE PHARMATECH CO., LTD.: Q4 2024 Earnings Release
23/04/2025 21:01 GALAPAGOS NV: Q1 2025 Earnings Release
23/04/2025 15:24 SYNGENE INTERNATIONAL LIMITED: Q4 2025 Earnings Release
23/04/2025 06:15 EUROFINS SCIENTIFIC SE: Q1 2025 Sales and Revenue Release - Trading Update
22/04/2025 SINO BIOLOGICAL,INC.: Q1 2025 Earnings Release (Projected)
22/04/2025 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2024 Earnings Release
21/04/2025 SHANGHAI MEDICILON INC.: Q4 2024 Earnings Release
21/04/2025 21:15 MEDPACE HOLDINGS, INC.: Q1 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock
  4. Calendar Celltrion, Inc.
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition